Navigation Links
Diageo Sponsors Medical Society of the State of New York's Physicians Training Program
Date:9/17/2007

NORWALK, Conn., Sept. 17 /PRNewswire-FirstCall/ -- Diageo (NYSE: DEO), the world's leading spirits, wine and beer company, is proud to announce its sponsorship of a physician's training program in screening and brief intervention techniques developed by the Medical Society of the State of New York (MSSNY).

The program, funded entirely by Diageo as an unrestricted grant, is being developed to better prepare physicians to address and assess issues related to alcohol abuse. This training program is being designed for physicians in four medical disciplines using the NIAAA's screening and brief intervention tool for use in primary care settings and the emergency department. Numerous clinical trials, including those sponsored by NIAAA and the World Health Organization, have shown that screening and brief interventions by physicians can play a pivotal role in helping patients that abuse alcohol.

"Diageo is proud to support the MSSNY brief intervention program which is in alignment with our commitment to responsible drinking," said Guy Smith, Executive Vice President of Diageo North America. Smith continued, "This collaborative effort is a first for our industry and hopefully the beginning of a step change in the way we address the misuse of beverage alcohol."

The program is comprised of a physician training module that includes formal presentations, an online program and a CD, all containing the tools necessary to conduct the screening and guidelines for implementing brief interventions. The initiative will also be supported by an awareness campaign as well as pre- and post-physician evaluations of the program.

The program will train physicians first to screen patients and to assess whether they are fa
'/>"/>

SOURCE Diageo
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Madison company cosponsors young entrepreneur awards
2. MGE Sponsors New Business Center for Entrepreneurs
3. Medical College receives $377K to study brain disease
4. Barriers will not stop convergence of medical technologies
5. Medical College team creates website for tracking flu
6. Biomedical engineering conference invites manufacturers
7. Visions: Wade offers straight talk on e-medical records
8. Merge unveils updated medical imaging software
9. Medical College receives $1.4M cancer grant
10. Medical technology firm lands $100K federal grant
11. Doyle outlines spending for Medical College, UWM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... 2015 The Pittcon 2015 Exposition, ... Ernest N. Morial Convention Center in New Orleans, ... February 19, 2015) displaying products and services used ... government labs. The Exposition will offer the latest ... to, analytical chemistry; drug discovery; nanotechnology; life sciences ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Favrille, Inc. (Nasdaq:,FVRL) today announced that it ... 2008 indicating that, for the last 30 consecutive ... common stock has been below,the minimum $1.00 per ... $5,000,000 minimum market value of publicly held shares ...
... the ... Treatment of Stuttering, ROANOKE, Va., ... non-profit research and,clinical center ( http://www.stuttering.org ) specializing ... stuttering,therapy with advanced behavioral, electronic and computer technologies that,significantly improve ...
... for Aging Services Technologies, (CAST) to Expedite Emerging ... 15 Samarion CEO Mark Rodgers was,recently named ... to help lead the charge to expedite emerging ... an international coalition ensuring that technology solutions,attain their ...
Cached Biology Technology:Favrille Announces Receipt of Nasdaq Letters 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 3Samarion CEO Mark Rodgers Named CAST Commissioner 2
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... HAIFA, Israel , April 27, 2010 Oil Refineries,Ltd. (TASE: ... its Annual & Special General,Meeting scheduled for Monday, April 26, 2010 to Monday, ... remains the same. , , , ... , , ...
... , April 27, 2010 Cellcom Israel,Ltd. (NYSE: ... of a purported,class action lawsuit filed in March 2009 ... by a plaintiff alleging to be the Company,s,subscriber, in connection ... The purported class action was dismissed,without prejudice, following the request ...
... Tuesday morning between Temple University Hospital (TUH) and the Pennsylvania Association of ... resume later today at 1:00 p.m. , ... Continued progress was reported, but the parties remain apart on economics. , ... Temple University Hospital is committed to meet with the ...
Cached Biology News:Oil Refineries Announces Delay to Annual & Special General Meeting 2Cellcom Israel Ltd. Announces Dismissal of a Purported Class Action 2
... 2-3x faster than western blotting. Get results ... Direct on gel detection. Eliminates the need ... detection methods. All reagents are ready-to-use. No ... to use. Only 2 reagents required. Guarantees a ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
... This kit is designed to knockout or alter ... less than one week. Red/ET recombination allows the ... precise, specific, and faithful manner. An FRT-flanked kanamycin ... which can be used to replace a gene ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: